Vimarsana
Biggest News Aggregation in the World

Areata Phase News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Areata Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Areata Phase Today - Breaking & Trending Today

Equillium Announces Update on Multi-Cytokine Inhibitors EQ101 & EQ102 in Development for Alopecia Areata and Celiac Disease - Vimarsana News

Equillium Announces Update on Multi-Cytokine Inhibitors EQ101 & EQ102 in Development for Alopecia Areata and Celiac Disease

Published: December 21, 2023

EQ101 Phase 2 study in alopecia areata is fully enrolled with topline data expected in Q2 2024 EQ302, an orally delivered multi-cytokine inhibitor of IL-15 & IL-21, will be advanced in place of...

Source: marketscreener.com
Related Topics:
New ZealandSteve ConnellyEquillium IncOno Pharmaceutical Co LtdBruce SteelAreata PhaseBaseline CharacteristicsVery SevereBiocon Limited
Equillium Announces Update on Multi-Cytokine Inhibitors EQ101 & EQ102 in Development for Alopecia Areata and Celiac Disease - Vimarsana News

Equillium Announces Update on Multi-Cytokine Inhibitors EQ101 & EQ102 in Development for Alopecia Areata and Celiac Disease

Published: December 21, 2023

21.12.2023 - Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced an update on multi-cytokine programs EQ101 in development for the ... Seite 1

Source: wallstreet-online.de
Related Topics:
Areata PhaseBaseline CharacteristicsVery Severe